Aclarion to Showcase Key 2026 Catalysts and Strong Balance Sheet at ROTH Conference

Tuesday, Mar 17, 2026 6:02 am ET1min read
ACON--

Aclarion, a healthcare technology company, will participate in the 38th Annual ROTH Conference to discuss its progress advancing Nociscan, a proprietary MR spectroscopy platform designed to help physicians identify painful discs in patients with chronic low back pain. CEO Brent Ness will engage in one-on-one meetings with institutional investors and analysts to discuss the company's progress and upcoming catalysts. The company has a strong balance sheet and plans to expand adoption of Nociscan in the UK and US.

Aclarion to Showcase Key 2026 Catalysts and Strong Balance Sheet at ROTH Conference

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet